切换至 "中华医学电子期刊资源库"
高级检索
中华肝脏外科手术学电子杂志

中华肝脏外科手术学电子杂志 ›› 2019, Vol. 08 ›› Issue (01) : 26 -30. doi: 10.3877/cma.j.issn.2095-3232.2019.01.007

所属专题： 文献；

临床研究

肿块型肝内胆管细胞癌手术切除预后影响因素分析
赵向前1,†(), 梁斌1, 张航宇1, 冯健1   
  1. 1. 100853　北京，解放军总医院肝胆外科
  • 收稿日期:2018-10-18 出版日期:2019-02-10
  • 通信作者: 赵向前

Analysis of prognostic impact factors of patients with mass-forming intrahepatic cholangiocarcinoma after surgical resection

Xiangqian Zhao1,†(), Bin Liang1, Hangyu Zhang1, Jian Feng1   

  1. 1. Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing 100853, China
  • Received:2018-10-18 Published:2019-02-10
  • Corresponding author: Xiangqian Zhao
  • About author:
    Corresponding author: Zhao Xiangqian, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

赵向前, 梁斌, 张航宇, 冯健. 肿块型肝内胆管细胞癌手术切除预后影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2019, 08(01): 26-30.

Xiangqian Zhao, Bin Liang, Hangyu Zhang, Jian Feng. Analysis of prognostic impact factors of patients with mass-forming intrahepatic cholangiocarcinoma after surgical resection[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(01): 26-30.

目的

探讨肿块型肝内胆管细胞癌（ICC）手术切除预后相关危险因素。

方法

回顾性分析2010年1月至2016年10月在解放军总医院行手术切除的48例肿块型ICC患者临床资料。患者均签署知情同意书，符合医学伦理学规定。其中男33例，女15例；年龄29～73岁，中位年龄53岁。肿瘤位于肝右叶37例，肝左叶11例；肿瘤平均直径（6.8±2.6）cm；所有患者均行R0切除。将患者临床病理参数纳入预后影响因素分析，单因素分析采用Kaplan-Meier法和Log-rank检验，多因素分析采用Cox比例风险回归模型。

结果

随访期间死亡28例，存活20例，生存时间3～82个月，中位生存时间20个月，1、3、5年生存率分别为95.7%、50.9%、14.8%。单因素分析显示，HBsAg、肿瘤分化程度、淋巴结转移、脉管受侵是肿块型ICC患者手术切除预后的影响因素（χ2= 4.097，6.415，11.069，9.117；P<0.05）。多因素分析显示，淋巴结转移是影响肿块型ICC患者手术切除预后的独立危险因素（HR=3.306，95%CI：1.184～9.233；P<0.05）。

结论

淋巴结转移是影响肿块型ICC患者手术切除预后的独立危险因素。

关键词: 肝内胆管细胞癌, 肝切除术, 预后, 危险因素
Objective

To investigate the risk factors of clinical prognosis of mass-forming intrahepatic cholangiocarcinoma (ICC) patients after surgical resection.

Methods

Clinical data of 48 patients with mass-forming ICC who underwent surgical resection in PLA General Hospital from January 2010 to October 2016 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 33 patients were male and 15 were female, aged from 29 to 73 years with a median age of 53 years. Tumors were located in the right lobe of the liver in 37 cases and left lobe in 11 cases. The mean tumor diameter was (6.8±2.6) cm. All patients underwent R0 resection. The clinicopathological parameters were included in the analysis of prognostic factors. Kaplan-Meier survival curve and Log-rank test were conducted for univariate analysis. Cox's proportional hazard model was conducted for multivariate analysis.

Results

During the postoperative follow-up, 28 cases died and 20 cases survived. The survival time was 3-82 months with a median survival time of 20 months. The 1-, 3- and 5-year survival rate was 95.7%, 50.9% and 14.8%, respectively. Univariate analysis indicated that HBsAg, degree of tumor differentiation, lymph node metastasis and vascular invasion were the impact factors for the survival prognosis (χ2=4.097, 6.415, 11.069, 9.117; P<0.05). Multivariate analysis revealed that lymph node metastasis was an independent risk factor for the prognosis of patients undergoing surgical resection (HR=3.306, 95%CI: 1.184-9.233; P<0.05).

Conclusion

Lymph node metastasis is an independent risk factor for the clinical prognosis of mass-forming ICC patients after surgical resection.

Key words: Intrahepatic cholangiocarcinoma, Hepatectomy, Prognosis, Risk factors
表1 影响肿块型ICC患者手术切除预后单因素分析（%）
影响因素 例数 1年 3年 5年 χ2值 P值
性别 ? ? ? ? 0.455 0.500
? 男 33 93.8 49.8 18.7 ? ?
? 女 15 90.0 54.0 13.5 ? ?
年龄（岁） ? ? ? ? 0.087 0.768
? ≤53 27 92.3 48.6 21.2 ? ?
? > 53 21 100.0 66.7 10.0 ? ?
HBsAg ? ? ? ? 4.097 0.043
? 阴性 35 97.1 59.0 23.3 ? ?
? 阳性 13 92.3 30.8 0 ? ?
CA19-9 ? ? ? ? 0.137 0.711
? 阴性 26 96.0 53.9 12.9 ? ?
? 阳性 22 95.5 46.0 20.5 ? ?
手术切除范围 ? ? ? ? 0.083 0.773
? 局部 25 96.0 50.6 11.4 ? ?
? 段/叶 23 95.5 51.7 19.4 ? ?
肿瘤直径（cm） ? ? ? ? 3.259 0.071
? ≤7 28 92.9 69.6 16.9 ? ?
? > 7 20 100.0 35.7 8.9 ? ?
肿瘤分化程度 ? ? ? ? 6.415 0.040
? 低分化 20 89.7 34.5 0 ? ?
? 中-低分化 18 100.0 78.0 25.3 ? ?
? 中分化 10 100.0 35.7 35.7 ? ?
淋巴结转移 ? ? ? ? 9.117 0.003
? 阴性 35 85.3 72.5 21.7 ? ?
? 阳性 13 92.3 12.8 0 ? ?
肿瘤位置 ? ? ? ? 0.244 0.621
? 肝左叶 11 100.0 66.7 33.3 ? ?
? 肝右叶 37 94.4 47.8 13.4 ? ?
切缘宽度（cm） ? ? ? ? 0.834 0.361
? ≤1 21 95.2 40.3 16.1 ? ?
? > 1 27 96 57.3 14.6 ? ?
脉管受侵 ? ? ? ? 11.069 0.001
? 无 37 97.1 66.3 10.1 ? ?
? 有 11 90.9 36.4 0 ? ?
图1 肿块型ICC患者手术切除术后Kaplan-Meier生存曲线
表2 影响肿块型ICC患者手术切除预后的多因素分析
影响因素 b SE（b） wald χ2 HR 95%CI P值
HBsAg阳性 0.133 0.504 0.070 1.143 0.425～3.070 0.791
低分化 -0.021 0.358 0.004 0.979 0.485～1.976 0.953
淋巴结转移 1.196 0.524 5.209 3.306 1.184～9.233 0.022
脉管受侵 1.018 0.541 3.542 2.769 0.959～7.995 0.060
[1]
Dover LL, Jacob R, Wang TN, et al. Improved postoperative survival for intraductal-growth subtype of intrahepatic cholangiocarcinoma[J]. Am Surg, 2016, 82(11):1133-1139.
[2]
王庆亮，许世磊，张鹏，等．AFP阳性肝内胆管细胞癌患者的临床特征及其预后影响因素[J/CD]．中华肝脏外科手术学电子杂志，2014, 3(6):39-42.
[3]
李浩，张正筠，周尊强，等．丙型肝炎病毒感染与胆管细胞癌发生风险关系的Meta分析[J/CD]．中华肝脏外科手术学电子杂志，2015, 4(2):79-83.
[4]
Tang H, Lu W, Li B, et al. Influence of surgical margins on overall survival after resection of intrahepatic cholangiocarcinoma: a meta-analysis[J]. Medicine, 2016, 95(35):e4621.
[5]
Zhou HB, Wang H, Li YQ, et al. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection[J]. World J Gastroenterol, 2011, 17(10):1292-1303.
[6]
Liu RQ, Shen SJ, Hu XF, et al. Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors[J]. Cancer Cell Int, 2013, 13(1):99.
[7]
Kim Y, Spolverato G, Amini N, et al. Surgical management of intrahepatic cholangiocarcinoma: defining an optimal prognostic lymph node stratification schema[J]. Ann Surg Oncol, 2015, 22(8):2772-2778.
[8]
Reddy SK, Hyder O, Marsh JW, et al. Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2013, 17(4):748-755.
[9]
De Rose AM, Cucchetti A, Clemente G, et al. Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma[J]. J Gastrointest Surg, 2013, 17(4):739-747.
[10]
Li YY, Li H, Lv P, et al. Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment[J]. J Gastrointest Surg, 2011, 15(4):608-613.
[11]
Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2015, 22(12):4020-4028.
[12]
Ribero D, Pinna AD, Guglielmi A, et al. Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients[J]. Arch Surg, 2012, 147(12):1107-1113.
[13]
Murakami S, Ajiki T, Okazaki T, et al. Factors affecting survival after resection of intrahepatic cholangiocarcinoma[J]. Surg Today, 2014, 44(10):1847-1854.
[14]
Spolverato G, Ejaz A, Kim Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2014, 18(7):1284-1291.
[15]
Lin ZY, Liang ZX, Zhuang PL, et al. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels[J]. BMC Cancer, 2016, 16(1):792.
[16]
Zhou H, Jiang X, Li Q, et al. A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma[J]. Am J Cancer Res, 2015, 5(5):1831-1843.
[17]
王庆亮，叶小鸣，胡昆鹏，等．肝内胆管细胞癌预后及其影响因素分析[J]．中国实用外科杂志，2014, 34(8):768-770.
[18]
Sanada Y, Kawashita Y, Okada S, et al. Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma[J]. World J Gastrointest Pathophysiol, 2014, 5(3):188-199.
[19]
Morine Y, Shimada M. The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics[J]. J Gastroenterol, 2015, 50(9):913-927.
[20]
王宏伟，邢宝才．肝内胆管细胞癌淋巴结清扫争议[J]．中国普通外科杂志，2016, 25(7):947-951.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[7] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[8] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[9] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[10] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[11] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[12] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[13] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号

AI
小
编
AI小编
你好！我是《中华医学电子期刊资源库》AI小编，有什么可以帮您的吗？